THE DUO Adapt™ SYSTEM

A whole new kind of accessibility.

DUO Adapt™ is designed to improve quality of life while expanding the treatable patient population and enabling physicians to treat patients.

System Overview

CroíValve has developed a novel, minimally invasive solution for severe+ Tricuspid Regurgitation (TR). TR is a highly prevalent disease in people over 65 years of age with limited treatment options today. The DUO Adapt™ System is designed to expand these treatment options.

Treat more patients. Enable more physicians.

The DUO Adapt™ System preserves the native anatomy with its novel design.

Coaptation Valve

The coaptation valve fills the leak and actively adapts to varying anatomy and leaks. DUO Adapt™ works in big hearts and small hearts, independent of coaptation gap and annulus size—working in tandem with the native leaflets—allowing it to treat a broad patient base, and support positive right heart remodeling.

Anchor System

To preserve the right heart, we created an anchor system that is adaptable and supportive of right heart remodeling. It’s anchored within the SVC with a stent, allowing the right heart to function without device interaction.

A bold new way to treat a broad patient population.

Large Annulus Sizes

Independent of the annulus size.

CIED Leads

Compatible with pre-existing CIED leads, adapts to the leak profile.

Large Coaptation Gaps

Independent of the coaptation gap size.

Advanced Disease

Designed to treat patients with advanced disease.

New. Adaptable. Scalable.

With a short learning curve to enable treatment of a broad population of patients, the DUO Adapt™ System can be deployed with ease while employing self centering technology for optimized positioning. The best aspect? Less reliance on expert imaging and the ability to treat complex anatomies and advanced-stage disease.

The clinical evidence is expanding.

The DUO Adapt Adapt™ System is currently under clinical investigation.

PCR 2024: 6 Month Follow Up with the CroíValve DUO System for the Percutaneous Treatment of Tricuspid Regurgitation in the TANDEM I Study
NY Valves 2025: DUO Tricuspid Coaptation Valve System: Long-Term Follow Up from the TANDEM I Study
London Valves 2025: Right Heart Remodeling after Transcatheter Tricuspid Valve Intervention with the DUO System in the TANDEM I Study
NY Valves 2026: Adaptive Coaptation for Treating TR